Beyond Breast and Ovarian Cancers: PARP Inhibitors for BRCA Mutation-Associated and BRCA-Like Solid Tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Beyond Breast and Ovarian Cancers: PARP Inhibitors for BRCA Mutation-Associated and BRCA-Like Solid Tumors

Published:2014 Issue: Volume:4 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

O’Sullivan Ciara C.,Moon Dominic H.,Kohn Elise C.,Lee Jung-Min

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antileukemic potential of methylated indolequinone MAC681 through immunogenic necroptosis and PARP1 degradation;Biomarker Research;2024-05-04

2. Efficacy and safety of PARP inhibitors combined with antiangiogenic agents in the maintenance treatment of ovarian cancer: a systematic review and meta-analysis with trial sequential analysis of randomized controlled trials;Frontiers in Pharmacology;2024-03-22

3. Pharmacodynamic effects of the PARP inhibitor talazoparib (MDV3800, BMN 673) in patients with BRCA-mutated advanced solid tumors;Cancer Chemotherapy and Pharmacology;2023-11-27

4. Hybrid Histone Deacetylase Inhibitor: An Effective Strategy for Cancer Therapy;Current Medicinal Chemistry;2023-06

5. Bioinformatic Analysis of BRCA for Breast, Ovary and Lung Cancer;2023 International Conference on Computational Intelligence and Sustainable Engineering Solutions (CISES);2023-04-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP